Skip to main content


Front. Psychiatry, 21 April 2021
Sec. Addictive Disorders

Corrigendum: Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment

\nMichael Specka
Michael Specka1*Thomas KuhlmannThomas Kuhlmann2Jürgen SawazkiJürgen Sawazki3Udo BonnetUdo Bonnet4Renate SteinertRenate Steinert5Monika Cybulska-RycickiMonika Cybulska-Rycicki6Helmut EichHelmut Eich7Benita ZeiskeBenita Zeiske8Antje NiederstebergAntje Niedersteberg9Luzia SchaafLuzia Schaaf3Norbert ScherbaumNorbert Scherbaum1
  • 1LVR Hospital Essen Department of Addictive Behaviour and Addiction Medicine, Medical Faculty, University of Duisburg-Essen, Essen, Germany
  • 2Psychosomatische Klinik Bergisch Gladbach, Bergisch Gladbach, Germany
  • 3LVR Clinic Viersen, Viersen, Germany
  • 4Castrop-Rauxel Evangelical Hospital, Castrop-Rauxel, Germany
  • 5LWL-Klinik Münster, Münster, North Rhine-Westphalia, Germany
  • 6LVR Clinic Langenfeld, Langenfeld, Germany
  • 7Alexianer Hospital, Krefeld, Germany
  • 8Alexius/Josef Hospital, Neuss, Germany
  • 9LVR Clinic Düren, Düren, Germany

A Corrigendum on
Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment

by Specka, M., Kuhlmann, T., Sawazki, J., Bonnet, U., Steinert, R., Cybulska-Rycicki, M., et al. (2020). Front. Psychiatry 11:569. doi: 10.3389/fpsyt.2020.00569

In the published article, there was an error in affiliation 7 Instead of “Clinic Maria Hilf GmbH, Moenchengladbach, Germany” it should be “Alexianer Hospital, Krefeld, Germany.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: novel psychoactive substances, pregabalin abuse, multiple substance use, drug dependence, drug detoxification, opiate dependents

Citation: Specka M, Kuhlmann T, Sawazki J, Bonnet U, Steinert R, Cybulska-Rycicki M, Eich H, Zeiske B, Niedersteberg A, Schaaf L and Scherbaum N (2021) Corrigendum: Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment. Front. Psychiatry 12:681542. doi: 10.3389/fpsyt.2021.681542

Received: 16 March 2021; Accepted: 17 March 2021;
Published: 21 April 2021.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2021 Specka, Kuhlmann, Sawazki, Bonnet, Steinert, Cybulska-Rycicki, Eich, Zeiske, Niedersteberg, Schaaf and Scherbaum. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Michael Specka,

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.